Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc R Desnoyers

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|March 8, 2012
FGF19 and cancerBenjamin C Lin, Luc R Desnoyers
The Journal of Biological Chemistry|July 14, 2007
Liver-specific activities of FGF19 require Klotho betaBenjamin C Lin, Manping Wang, Craig Blackmore, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
Plos One|May 23, 2012
Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse modelsDorothy M French, Benjamin C Lin, Manping Wang, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|March 8, 2012
FGF19 and cancerBenjamin C Lin, Luc R Desnoyers
The Journal of Biological Chemistry|July 14, 2007
Liver-specific activities of FGF19 require Klotho betaBenjamin C Lin, Manping Wang, Craig Blackmore, et al.
Clinical Pharmacology and Therapeutics|July 19, 2020
Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072Mark Stroh, Michelle Green, Bjorn L Millard, et al.
Plos One|May 23, 2012
Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse modelsDorothy M French, Benjamin C Lin, Manping Wang, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 1